Revolutionizing Venous Thromboembolism Prevention: Introducing QIJIA's Intermittent Pulsed Compression Thrombosis Systems
Venous thromboembolism (VTE) remains a critical challenge in modern healthcare, requiring cutting-edge solutions to safeguard patient outcomes. Enter QIJIA, a trailblazer in medical technology, and its game-changing Intermittent Pulsed Compression Thrombosis Systems—the QJ-B300, QJ-B400, and QJ-H400. Engineered for precision, adaptability, and patient-centric care, these systems are redefining VTE prevention across healthcare settings.
Why QIJIA’s System Stands Apart
QIJIA’s technology merges smart adaptability, clinical efficacy, and patient comfort into a seamless solution. Here’s what sets it apart:
1. Smart Adaptability to Meet Diverse Clinical Needs
Three Modes of Operation: Gradient compression, constant pressure, or isolated foot pump—tailored to specific patient scenarios.
30+ Customizable Programs: Choose from 22 pre-programmed modes or craft 8+ personalized regimens for unmatched flexibility.
Integrated Pneumatic Therapy: Combines traditional foot pumps, pulsed foot pumps, gradient systems, and airwave technology into adaptive, multi-modal treatment.
2. Enhanced Efficiency & Safety
Dual Overpressure Protection: Hardware and software safeguards ensure safe treatment delivery, with under-pressure alerts for peace of mind.
Wide Pressure Range: Adjustable from 0 to 300 mmHg to accommodate patients with varying sensitivities and conditions.
3. Unparalleled Convenience
Space-Saving, Portable Design: Lightweight and featuring multiple hanging positions for effortless interdepartmental transport.
Quiet & Automated Operation: Silent performance and one-touch controls streamline workflow and reduce staff burden.
4. Superior Patient Comfort
Ergonomic Accessories: Breathable foot covers, multi-chamber cuffs, and dual-channel airflow design ensure comfort during extended use.
Clinical Mechanism: How It Works
QIJIA’s technology harnesses cyclic pneumatic compression to optimize circulation:
Sequential Inflation/Deflation: Multi-chamber cuffs rhythmically compress limbs, promoting venous return, enhancing arterial perfusion, and improving blood/lymphatic flow.
Clot Prevention: Inhibits fibrin aggregation, boosts fibrinolysis, and deters vascular endothelial adhesion to prevent DVT and edema.
Technical Specifications
Pressure Range: 0–300 mmHg
Treatment Duration: 0–600 minutes
Refill Time: 20–70 seconds
Targeted Areas: Hips, hands, feet, and legs
Widespread Medical Applicability
QIJIA’s systems excel in over 15 departments, including:
ICU & Emergency Medicine
Vascular Surgery & Cardiology
Oncology & General Surgery
Pulmonology & Nephrology
Their versatility supports postoperative recovery, chronic disease management, and proactive care strategies.
Form Meets Functionality
The sleek teal-and-white aesthetic embodies QIJIA’s dedication to usability and professionalism. Intuitive navigation—from product insights to technical details—ensures seamless integration into clinical workflows.
Why Choose QIJIA?
Evidence-Based Outcomes: Proven to mitigate VTE risk through enhanced circulation and fibrinolytic function.
Forward-Thinking Innovation: Blending cutting-edge technology with practical design to meet evolving clinical demands.
Cross-Departmental Impact: A single solution for multiple specialties, optimizing hospital resources.
Empower Your Clinic with QIJIA
In today’s healthcare landscape, VTE prevention is non-negotiable. QIJIA’s Intermittent Pulsed Compression Thrombosis Systems deliver precision, safety, and flexibility—from critical care to outpatient settings. Elevate clinical standards and patient quality with devices designed to make a difference.
Experience QIJIA’s Innovation Today
Where innovation meets human touch.
Discover the QJ-B300, QJ-B400, and QJ-H400 systems and transform your VTE prevention strategy.
Keywords: QIJIA, Intermittent Pulsed Compression, Thrombosis Prevention, QJ-B300, QJ-H400, Venous Thromboembolism, Clinical Innovation, Medical Devices